Document is current
Any future updates will be listed below
-
Authors
Okamoto, Kentaro https://orcid.org/0000-0001-5677-4222
- License Information
-
More Information
Article History
Received: 7 January 2026
Accepted: 25 February 2026
First Online: 26 May 2026
Declarations
:
: Kentaro Okamoto has received honoraria for invited lectures from Biogen Japan (2021) and Chugai Pharmaceutical Co., Ltd. (a member of the Roche Group) (2022). The author declares no other conflicts of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.
